FDA Inspection 777697 — Medeast Post OP & Surgical

Medeast Post OP & Surgical — FEI 3004081070

The FDA completed an inspection of Medeast Post OP & Surgical on Apr 19, 2012 in Mount Laurel, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 19, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mount Laurel, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.